Adrenal Cancer

Protocol #Sponsor Protocol TItle
NCT01772004

EMD Serono
EMR 100070-001, 2013-002834-19





A Phase I, Open-label, Multiple-Ascending Dose Trial to Investigate the Safety, Tolerability, Pharmacokinetics, Biological and Clinical Activity of Avelumab (MSB0010718C) in Subjects With Metastatic or Locally Advanced Solid Tumors and Expansion to Selected Indications